LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro (Q47975079)

7 February 2018

title

LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro (English)

1 reference

7 February 2018

author name string

E Schnitzer

1

1 reference

7 February 2018

I Pinchuk

2

1 reference

7 February 2018

M Fainaru

3

1 reference

7 February 2018

D Lichtenberg

4

1 reference

7 February 2018

S Yedgar

5

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

Free Radical Biology and Medicine

published in

1 reference

7 February 2018

volume

24

1 reference

7 February 2018

issue

7-8

1 reference

7 February 2018

page(s)

1294-1303

1 reference

7 February 2018

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Role of oxidatively modified LDL in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Antioxidants and the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Chemistry and pathophysiology of oxidation of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Apolipoprotein B exhibits phospholipase A1 and phospholipase A2 activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Scavenging of lipid peroxidation products from oxidizing LDL by albumin alters the plasma half-life of a fraction of oxidized LDL particles

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Oxidation of Low Density Lipoprotein Upon Sequential Exposure to Copper Ions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Effect of platelet activating factor on the kinetics of LDL oxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

The effect of albumin on copper-induced LDL oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Continuous monitoring of intermediates and final products of oxidation of low density lipoprotein by means of UV-spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Hydrolysis of a fluorescent phospholipid substrate by phospholipase A2 and lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

The use of C6-NBD-PC for assaying phospholipase A2-activity: scope and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

Inhibition of LDL-associated phospholipase A activity in human plasma by albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2897%2900454-1

7 January 2021

10.1016/S0891-5849(97)00454-1

Identifiers

DOI

1 reference

7 February 2018

release_rrhzrpj45fgrzhbcgmhovrrgs4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rrhzrpj45fgrzhbcgmhovrrgs4

24 November 2022

mapped directly with Wikidata item

PubMed ID

9626586

1 reference

7 February 2018